David Miceli

David Miceli has taken a leadership role in a variety of pharmaceutical litigation cases, including a Nutraquest test case that ultimately led to settlements exceeding $35 million for more than 150 plaintiffs.* He was also selected to serve as the plaintiff’s mediation liaison in the Nutraquest case.  

David is a founding member of the American Association for Justice’s (formerly ATLA) Cox-2 Litigation Group, and has led client-centric efforts on Vioxx, Bextra, Celebrex, PPA, Ephedra and Baycol as well. In addition, he has authored several articles on pharmaceuticals and torts, and also has extensive experience in litigating complex medical cases, including medical malpractice and nursing-home neglect cases.

* Please note that recovery results vary per client. The recovery amounts in each case reflect the specific facts of that case. Further, recovery amounts in past cases are not a guarantee of future results.

Contact Information

119 Maple Street, Suite 201
Carrollton, GA 30117
(770) 834-2122
(770) 214-2622

Noteworthy

• Test Case Trial Counsel, In re: Nutraquest, Inc. Litigation, USDC-NJ
• Member/Coordinating Counsel. In re: Nutraquest, Inc. Litigation, USDC-NJ
• Mediation Liaison Counsel, In re: Nutraquest, Inc. Litigation, USDC-NJ
• PPA MDL, Discovery Team (Perrigo, Inc.); USDC-WA
• Founder, Cox-2 Litigation Group (AAJ)

News & Publications

May 2003 Presentation, "VIOXX, Should We Litigate This Drug?"; AAJ Emerging Drug Litigation, Chicago, IL

July 2003, Founded Cox-2 Litigation Group; AAJ Annual Meeting, Atlanta, GA
 
July 2004, Moderator/Panelist, VIOXX: An Update on Discovery and Status of the Litigation; AAJ Annual Meeting, Boston, MA
 
Spring 2003 Presentation: How to Market for Mass Tort Cases; Mass Torts Made Perfect, Las Vegas, NV

Professional & Community Affiliations

• American Association for Justice
• Baycol Litigation Group (AAJ)
• PPA Litigation Group (AAJ)
• Ephedra Litigation Group (AAJ)
• Founder, Cox-2 Litigation Group (AAJ)